Residual cancer cells after apparent complete pathological response to neoadjuvant therapy in oesophageal adenocarcinoma.

Autor: Walker RC; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Harrington J; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Breininger SP; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Pickering O; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Hill SL; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Sharpe BP; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Grace B; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Reddin I; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Rajak R; Pathology, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Manousopoulou A; Proteome Exploration Laboratory, Beckman Institute, California Institute of Technology, Pasedena, California, USA., Garbis SD; Proteome Exploration Laboratory, Beckman Institute, California Institute of Technology, Pasedena, California, USA., Walters ZS; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Rose-Zerilli MJJ; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK., Underwood TJ; School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
Jazyk: angličtina
Zdroj: The British journal of surgery [Br J Surg] 2024 Apr 03; Vol. 111 (4).
DOI: 10.1093/bjs/znae103
Databáze: MEDLINE